Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantation

Am J Hematol. 2019 Feb;94(2):E48-E50. doi: 10.1002/ajh.25352. Epub 2018 Nov 29.

Authors

Giacomo Andreani¹, Matteo Dragani¹, Anna Serra¹, Paolo Nicoli¹, Marco De Gobbi¹, Daniela Cilloni¹

Affiliation

¹ Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

PMID: 30431666
DOI: 10.1002/ajh.25352

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bridged Bicyclo Compounds, Heterocyclic / administration & dosage*
Decitabine / administration & dosage*
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / therapy
Male
Middle Aged
Remission Induction / methods*
Salvage Therapy / methods
Sulfonamides / administration & dosage*
Treatment Outcome

Substances

Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
Decitabine
venetoclax